nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—Indinavir—acquired immunodeficiency syndrome	0.229	0.54	CrCtD
Nelfinavir—Saquinavir—acquired immunodeficiency syndrome	0.195	0.46	CrCtD
Nelfinavir—Indinavir—Lopinavir—acquired immunodeficiency syndrome	0.0652	0.257	CrCrCtD
Nelfinavir—Indinavir—Saquinavir—acquired immunodeficiency syndrome	0.0606	0.239	CrCrCtD
Nelfinavir—Saquinavir—Indinavir—acquired immunodeficiency syndrome	0.0515	0.203	CrCrCtD
Nelfinavir—Saquinavir—Lopinavir—acquired immunodeficiency syndrome	0.0471	0.186	CrCrCtD
Nelfinavir—Mitiglinide—Saquinavir—acquired immunodeficiency syndrome	0.0291	0.115	CrCrCtD
Nelfinavir—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.00717	0.0301	CbGbCtD
Nelfinavir—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.00677	0.0284	CbGbCtD
Nelfinavir—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.00633	0.0265	CbGbCtD
Nelfinavir—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0063	0.0264	CbGbCtD
Nelfinavir—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0063	0.0264	CbGbCtD
Nelfinavir—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.00594	0.0249	CbGbCtD
Nelfinavir—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.00594	0.0249	CbGbCtD
Nelfinavir—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.00555	0.0233	CbGbCtD
Nelfinavir—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.00515	0.0216	CbGbCtD
Nelfinavir—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.00484	0.0203	CbGbCtD
Nelfinavir—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.00484	0.0203	CbGbCtD
Nelfinavir—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.00472	0.0198	CbGbCtD
Nelfinavir—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.00472	0.0198	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0046	0.0193	CbGbCtD
Nelfinavir—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0046	0.0193	CbGbCtD
Nelfinavir—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.00452	0.019	CbGbCtD
Nelfinavir—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.00438	0.0184	CbGbCtD
Nelfinavir—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.00412	0.0173	CbGbCtD
Nelfinavir—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00397	0.0166	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00397	0.0166	CbGbCtD
Nelfinavir—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00381	0.016	CbGbCtD
Nelfinavir—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0035	0.0147	CbGbCtD
Nelfinavir—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00349	0.0146	CbGbCtD
Nelfinavir—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00349	0.0146	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00349	0.0146	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00349	0.0146	CbGbCtD
Nelfinavir—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00345	0.0145	CbGbCtD
Nelfinavir—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00345	0.0145	CbGbCtD
Nelfinavir—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00332	0.0139	CbGbCtD
Nelfinavir—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00327	0.0137	CbGbCtD
Nelfinavir—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00308	0.0129	CbGbCtD
Nelfinavir—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00302	0.0127	CbGbCtD
Nelfinavir—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00298	0.0125	CbGbCtD
Nelfinavir—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00284	0.0119	CbGbCtD
Nelfinavir—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.00284	0.0119	CbGbCtD
Nelfinavir—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00278	0.0117	CbGbCtD
Nelfinavir—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00278	0.0117	CbGbCtD
Nelfinavir—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00272	0.0114	CbGbCtD
Nelfinavir—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00261	0.011	CbGbCtD
Nelfinavir—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00261	0.011	CbGbCtD
Nelfinavir—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00257	0.0108	CbGbCtD
Nelfinavir—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00256	0.0107	CbGbCtD
Nelfinavir—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00256	0.0107	CbGbCtD
Nelfinavir—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.0104	CbGbCtD
Nelfinavir—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00248	0.0104	CbGbCtD
Nelfinavir—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0024	0.0101	CbGbCtD
Nelfinavir—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00234	0.0098	CbGbCtD
Nelfinavir—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00234	0.0098	CbGbCtD
Nelfinavir—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00231	0.00969	CbGbCtD
Nelfinavir—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00231	0.00969	CbGbCtD
Nelfinavir—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00225	0.00941	CbGbCtD
Nelfinavir—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00212	0.00886	CbGbCtD
Nelfinavir—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00212	0.00886	CbGbCtD
Nelfinavir—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00211	0.00884	CbGbCtD
Nelfinavir—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00211	0.00884	CbGbCtD
Nelfinavir—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00202	0.00847	CbGbCtD
Nelfinavir—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.002	0.00837	CbGbCtD
Nelfinavir—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00195	0.00815	CbGbCtD
Nelfinavir—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00194	0.00812	CbGbCtD
Nelfinavir—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00765	CbGbCtD
Nelfinavir—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00735	CbGbCtD
Nelfinavir—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00175	0.00735	CbGbCtD
Nelfinavir—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0017	0.00713	CbGbCtD
Nelfinavir—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0017	0.00713	CbGbCtD
Nelfinavir—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00168	0.00704	CbGbCtD
Nelfinavir—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.00684	CbGbCtD
Nelfinavir—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00672	CbGbCtD
Nelfinavir—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.00672	CbGbCtD
Nelfinavir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00158	0.00663	CbGbCtD
Nelfinavir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00149	0.00623	CbGbCtD
Nelfinavir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00149	0.00623	CbGbCtD
Nelfinavir—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00135	0.00564	CbGbCtD
Nelfinavir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.00564	CbGbCtD
Nelfinavir—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00529	CbGbCtD
Nelfinavir—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00487	CbGbCtD
Nelfinavir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00427	CbGbCtD
Nelfinavir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.00427	CbGbCtD
Nelfinavir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.000977	0.0041	CbGbCtD
Nelfinavir—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.000444	0.0637	CbGeAlD
Nelfinavir—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000289	0.0415	CbGeAlD
Nelfinavir—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000236	0.0339	CbGeAlD
Nelfinavir—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000228	0.0327	CbGeAlD
Nelfinavir—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000226	0.0325	CbGeAlD
Nelfinavir—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000224	0.0322	CbGeAlD
Nelfinavir—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000171	0.0245	CbGeAlD
Nelfinavir—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000171	0.0245	CbGeAlD
Nelfinavir—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000168	0.0241	CbGeAlD
Nelfinavir—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000163	0.0233	CbGeAlD
Nelfinavir—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000139	0.0199	CbGeAlD
Nelfinavir—SLC22A1—blood—acquired immunodeficiency syndrome	0.000137	0.0197	CbGeAlD
Nelfinavir—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000127	0.0183	CbGeAlD
Nelfinavir—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000127	0.0183	CbGeAlD
Nelfinavir—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000121	0.0174	CbGeAlD
Nelfinavir—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000116	0.0167	CbGeAlD
Nelfinavir—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000112	0.016	CbGeAlD
Nelfinavir—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000111	0.016	CbGeAlD
Nelfinavir—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000109	0.0156	CbGeAlD
Nelfinavir—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000107	0.0154	CbGeAlD
Nelfinavir—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000107	0.0154	CbGeAlD
Nelfinavir—CYP2C19—blood—acquired immunodeficiency syndrome	0.000106	0.0152	CbGeAlD
Nelfinavir—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000103	0.0148	CbGeAlD
Nelfinavir—CYP2C19—vagina—acquired immunodeficiency syndrome	9.82e-05	0.0141	CbGeAlD
Nelfinavir—CYP1A2—digestive system—acquired immunodeficiency syndrome	9.08e-05	0.013	CbGeAlD
Nelfinavir—ABCG2—blood—acquired immunodeficiency syndrome	8.99e-05	0.0129	CbGeAlD
Nelfinavir—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	8.81e-05	0.0127	CbGeAlD
Nelfinavir—CYP3A5—digestive system—acquired immunodeficiency syndrome	8.76e-05	0.0126	CbGeAlD
Nelfinavir—CYP2B6—digestive system—acquired immunodeficiency syndrome	8.7e-05	0.0125	CbGeAlD
Nelfinavir—ABCG2—bone marrow—acquired immunodeficiency syndrome	8.7e-05	0.0125	CbGeAlD
Nelfinavir—ABCG2—spinal cord—acquired immunodeficiency syndrome	8.66e-05	0.0124	CbGeAlD
Nelfinavir—CYP1A2—blood—acquired immunodeficiency syndrome	8.65e-05	0.0124	CbGeAlD
Nelfinavir—CYP2C9—digestive system—acquired immunodeficiency syndrome	8.62e-05	0.0124	CbGeAlD
Nelfinavir—SLC22A1—brain—acquired immunodeficiency syndrome	8.52e-05	0.0122	CbGeAlD
Nelfinavir—CYP3A5—blood—acquired immunodeficiency syndrome	8.34e-05	0.012	CbGeAlD
Nelfinavir—ABCG2—vagina—acquired immunodeficiency syndrome	8.33e-05	0.012	CbGeAlD
Nelfinavir—CYP2B6—blood—acquired immunodeficiency syndrome	8.29e-05	0.0119	CbGeAlD
Nelfinavir—CYP2C9—blood—acquired immunodeficiency syndrome	8.21e-05	0.0118	CbGeAlD
Nelfinavir—SLCO1A2—brain—acquired immunodeficiency syndrome	8.21e-05	0.0118	CbGeAlD
Nelfinavir—ABCG2—lung—acquired immunodeficiency syndrome	7.88e-05	0.0113	CbGeAlD
Nelfinavir—CYP3A5—vagina—acquired immunodeficiency syndrome	7.73e-05	0.0111	CbGeAlD
Nelfinavir—CYP2B6—vagina—acquired immunodeficiency syndrome	7.68e-05	0.011	CbGeAlD
Nelfinavir—CYP1A2—lung—acquired immunodeficiency syndrome	7.58e-05	0.0109	CbGeAlD
Nelfinavir—CYP3A5—lung—acquired immunodeficiency syndrome	7.31e-05	0.0105	CbGeAlD
Nelfinavir—CYP2B6—lung—acquired immunodeficiency syndrome	7.27e-05	0.0104	CbGeAlD
Nelfinavir—CYP2B6—nervous system—acquired immunodeficiency syndrome	6.73e-05	0.00967	CbGeAlD
Nelfinavir—ABCB1—retina—acquired immunodeficiency syndrome	6.62e-05	0.00951	CbGeAlD
Nelfinavir—CYP3A4—digestive system—acquired immunodeficiency syndrome	6.57e-05	0.00944	CbGeAlD
Nelfinavir—CYP2B6—central nervous system—acquired immunodeficiency syndrome	6.48e-05	0.00931	CbGeAlD
Nelfinavir—CYP2D6—digestive system—acquired immunodeficiency syndrome	6.47e-05	0.00929	CbGeAlD
Nelfinavir—CYP3A4—blood—acquired immunodeficiency syndrome	6.26e-05	0.00899	CbGeAlD
Nelfinavir—CYP2D6—blood—acquired immunodeficiency syndrome	6.16e-05	0.00885	CbGeAlD
Nelfinavir—ABCG2—brain—acquired immunodeficiency syndrome	5.58e-05	0.00801	CbGeAlD
Nelfinavir—ABCG2—lymph node—acquired immunodeficiency syndrome	5.39e-05	0.00774	CbGeAlD
Nelfinavir—CYP2B6—brain—acquired immunodeficiency syndrome	5.14e-05	0.00739	CbGeAlD
Nelfinavir—CYP3A4—nervous system—acquired immunodeficiency syndrome	5.08e-05	0.0073	CbGeAlD
Nelfinavir—CYP2D6—nervous system—acquired immunodeficiency syndrome	5e-05	0.00718	CbGeAlD
Nelfinavir—CYP3A4—central nervous system—acquired immunodeficiency syndrome	4.89e-05	0.00703	CbGeAlD
Nelfinavir—CYP2D6—central nervous system—acquired immunodeficiency syndrome	4.81e-05	0.00691	CbGeAlD
Nelfinavir—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	4.71e-05	0.00676	CbGeAlD
Nelfinavir—ABCB1—digestive system—acquired immunodeficiency syndrome	4.65e-05	0.00668	CbGeAlD
Nelfinavir—ABCB1—blood—acquired immunodeficiency syndrome	4.43e-05	0.00636	CbGeAlD
Nelfinavir—ABCB1—bone marrow—acquired immunodeficiency syndrome	4.29e-05	0.00616	CbGeAlD
Nelfinavir—ABCB1—spinal cord—acquired immunodeficiency syndrome	4.27e-05	0.00613	CbGeAlD
Nelfinavir—ABCB1—vagina—acquired immunodeficiency syndrome	4.11e-05	0.0059	CbGeAlD
Nelfinavir—ABCB1—lung—acquired immunodeficiency syndrome	3.88e-05	0.00558	CbGeAlD
Nelfinavir—CYP2D6—brain—acquired immunodeficiency syndrome	3.82e-05	0.00549	CbGeAlD
Nelfinavir—ABCB1—nervous system—acquired immunodeficiency syndrome	3.6e-05	0.00517	CbGeAlD
Nelfinavir—ABCB1—central nervous system—acquired immunodeficiency syndrome	3.46e-05	0.00497	CbGeAlD
Nelfinavir—Nausea—Amprenavir—acquired immunodeficiency syndrome	2.79e-05	0.000364	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	2.79e-05	0.000364	CcSEcCtD
Nelfinavir—Flatulence—Lamivudine—acquired immunodeficiency syndrome	2.78e-05	0.000363	CcSEcCtD
Nelfinavir—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000362	CcSEcCtD
Nelfinavir—Malaise—Ritonavir—acquired immunodeficiency syndrome	2.77e-05	0.000362	CcSEcCtD
Nelfinavir—Pain—Zidovudine—acquired immunodeficiency syndrome	2.76e-05	0.00036	CcSEcCtD
Nelfinavir—Asthenia—Nevirapine—acquired immunodeficiency syndrome	2.76e-05	0.00036	CcSEcCtD
Nelfinavir—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	2.76e-05	0.000359	CcSEcCtD
Nelfinavir—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	2.75e-05	0.000359	CcSEcCtD
Nelfinavir—ABCB1—brain—acquired immunodeficiency syndrome	2.75e-05	0.00395	CbGeAlD
Nelfinavir—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	2.75e-05	0.000358	CcSEcCtD
Nelfinavir—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	2.74e-05	0.000358	CcSEcCtD
Nelfinavir—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	2.74e-05	0.000357	CcSEcCtD
Nelfinavir—Anaemia—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000357	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	2.74e-05	0.000357	CcSEcCtD
Nelfinavir—Back pain—Lamivudine—acquired immunodeficiency syndrome	2.73e-05	0.000356	CcSEcCtD
Nelfinavir—Pruritus—Nevirapine—acquired immunodeficiency syndrome	2.72e-05	0.000355	CcSEcCtD
Nelfinavir—Vomiting—Didanosine—acquired immunodeficiency syndrome	2.72e-05	0.000355	CcSEcCtD
Nelfinavir—Agitation—Saquinavir—acquired immunodeficiency syndrome	2.72e-05	0.000355	CcSEcCtD
Nelfinavir—Insomnia—Indinavir—acquired immunodeficiency syndrome	2.72e-05	0.000354	CcSEcCtD
Nelfinavir—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	2.71e-05	0.000354	CcSEcCtD
Nelfinavir—Oedema—Delavirdine—acquired immunodeficiency syndrome	2.71e-05	0.000354	CcSEcCtD
Nelfinavir—Anorexia—Efavirenz—acquired immunodeficiency syndrome	2.7e-05	0.000353	CcSEcCtD
Nelfinavir—Rash—Didanosine—acquired immunodeficiency syndrome	2.7e-05	0.000352	CcSEcCtD
Nelfinavir—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	2.7e-05	0.000352	CcSEcCtD
Nelfinavir—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	2.7e-05	0.000352	CcSEcCtD
Nelfinavir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	2.69e-05	0.000351	CcSEcCtD
Nelfinavir—Headache—Didanosine—acquired immunodeficiency syndrome	2.68e-05	0.00035	CcSEcCtD
Nelfinavir—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	2.68e-05	0.000349	CcSEcCtD
Nelfinavir—Malaise—Saquinavir—acquired immunodeficiency syndrome	2.67e-05	0.000348	CcSEcCtD
Nelfinavir—Somnolence—Indinavir—acquired immunodeficiency syndrome	2.67e-05	0.000348	CcSEcCtD
Nelfinavir—Asthenia—Stavudine—acquired immunodeficiency syndrome	2.66e-05	0.000348	CcSEcCtD
Nelfinavir—Convulsion—Ritonavir—acquired immunodeficiency syndrome	2.66e-05	0.000348	CcSEcCtD
Nelfinavir—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	2.66e-05	0.000347	CcSEcCtD
Nelfinavir—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.000347	CcSEcCtD
Nelfinavir—ABCB1—lymph node—acquired immunodeficiency syndrome	2.66e-05	0.00382	CbGeAlD
Nelfinavir—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	2.65e-05	0.000346	CcSEcCtD
Nelfinavir—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	2.64e-05	0.000345	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	2.64e-05	0.000344	CcSEcCtD
Nelfinavir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	2.64e-05	0.000344	CcSEcCtD
Nelfinavir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	2.63e-05	0.000343	CcSEcCtD
Nelfinavir—Pruritus—Stavudine—acquired immunodeficiency syndrome	2.63e-05	0.000343	CcSEcCtD
Nelfinavir—Asthenia—Abacavir—acquired immunodeficiency syndrome	2.63e-05	0.000342	CcSEcCtD
Nelfinavir—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	2.62e-05	0.000342	CcSEcCtD
Nelfinavir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	2.62e-05	0.000342	CcSEcCtD
Nelfinavir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	2.62e-05	0.000341	CcSEcCtD
Nelfinavir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	2.62e-05	0.000341	CcSEcCtD
Nelfinavir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	2.61e-05	0.00034	CcSEcCtD
Nelfinavir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.00034	CcSEcCtD
Nelfinavir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	2.61e-05	0.00034	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	2.6e-05	0.000339	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	2.59e-05	0.000338	CcSEcCtD
Nelfinavir—Pruritus—Abacavir—acquired immunodeficiency syndrome	2.59e-05	0.000338	CcSEcCtD
Nelfinavir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	2.59e-05	0.000337	CcSEcCtD
Nelfinavir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	2.59e-05	0.000337	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	2.58e-05	0.000337	CcSEcCtD
Nelfinavir—Pain—Indinavir—acquired immunodeficiency syndrome	2.57e-05	0.000335	CcSEcCtD
Nelfinavir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	2.57e-05	0.000335	CcSEcCtD
Nelfinavir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	2.56e-05	0.000334	CcSEcCtD
Nelfinavir—Convulsion—Saquinavir—acquired immunodeficiency syndrome	2.56e-05	0.000334	CcSEcCtD
Nelfinavir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	2.55e-05	0.000333	CcSEcCtD
Nelfinavir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	2.55e-05	0.000333	CcSEcCtD
Nelfinavir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	2.55e-05	0.000332	CcSEcCtD
Nelfinavir—Malaise—Lamivudine—acquired immunodeficiency syndrome	2.55e-05	0.000332	CcSEcCtD
Nelfinavir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	2.54e-05	0.000331	CcSEcCtD
Nelfinavir—Nausea—Didanosine—acquired immunodeficiency syndrome	2.54e-05	0.000331	CcSEcCtD
Nelfinavir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	2.53e-05	0.00033	CcSEcCtD
Nelfinavir—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	2.53e-05	0.00033	CcSEcCtD
Nelfinavir—Somnolence—Efavirenz—acquired immunodeficiency syndrome	2.52e-05	0.000329	CcSEcCtD
Nelfinavir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	2.52e-05	0.000329	CcSEcCtD
Nelfinavir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	2.52e-05	0.000329	CcSEcCtD
Nelfinavir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	2.51e-05	0.000328	CcSEcCtD
Nelfinavir—Oedema—Ritonavir—acquired immunodeficiency syndrome	2.51e-05	0.000327	CcSEcCtD
Nelfinavir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	2.5e-05	0.000327	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	2.5e-05	0.000326	CcSEcCtD
Nelfinavir—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	2.5e-05	0.000326	CcSEcCtD
Nelfinavir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	2.49e-05	0.000325	CcSEcCtD
Nelfinavir—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	2.47e-05	0.000323	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	2.47e-05	0.000323	CcSEcCtD
Nelfinavir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	2.47e-05	0.000322	CcSEcCtD
Nelfinavir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000321	CcSEcCtD
Nelfinavir—Dizziness—Stavudine—acquired immunodeficiency syndrome	2.46e-05	0.00032	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	2.45e-05	0.00032	CcSEcCtD
Nelfinavir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	2.45e-05	0.00032	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	2.45e-05	0.000319	CcSEcCtD
Nelfinavir—Convulsion—Lamivudine—acquired immunodeficiency syndrome	2.45e-05	0.000319	CcSEcCtD
Nelfinavir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	2.45e-05	0.000319	CcSEcCtD
Nelfinavir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	2.44e-05	0.000318	CcSEcCtD
Nelfinavir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	2.44e-05	0.000318	CcSEcCtD
Nelfinavir—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	2.43e-05	0.000316	CcSEcCtD
Nelfinavir—Pain—Efavirenz—acquired immunodeficiency syndrome	2.43e-05	0.000316	CcSEcCtD
Nelfinavir—Rash—Nevirapine—acquired immunodeficiency syndrome	2.43e-05	0.000316	CcSEcCtD
Nelfinavir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	2.42e-05	0.000316	CcSEcCtD
Nelfinavir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	2.42e-05	0.000316	CcSEcCtD
Nelfinavir—Dizziness—Abacavir—acquired immunodeficiency syndrome	2.42e-05	0.000316	CcSEcCtD
Nelfinavir—Oedema—Saquinavir—acquired immunodeficiency syndrome	2.42e-05	0.000315	CcSEcCtD
Nelfinavir—Somnolence—Delavirdine—acquired immunodeficiency syndrome	2.41e-05	0.000315	CcSEcCtD
Nelfinavir—Headache—Nevirapine—acquired immunodeficiency syndrome	2.41e-05	0.000314	CcSEcCtD
Nelfinavir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	2.4e-05	0.000314	CcSEcCtD
Nelfinavir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	2.4e-05	0.000314	CcSEcCtD
Nelfinavir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	2.4e-05	0.000312	CcSEcCtD
Nelfinavir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000312	CcSEcCtD
Nelfinavir—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	2.39e-05	0.000312	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	2.39e-05	0.000311	CcSEcCtD
Nelfinavir—Urticaria—Indinavir—acquired immunodeficiency syndrome	2.38e-05	0.000311	CcSEcCtD
Nelfinavir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	2.37e-05	0.00031	CcSEcCtD
Nelfinavir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.00031	CcSEcCtD
Nelfinavir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.00031	CcSEcCtD
Nelfinavir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000308	CcSEcCtD
Nelfinavir—Vomiting—Stavudine—acquired immunodeficiency syndrome	2.36e-05	0.000308	CcSEcCtD
Nelfinavir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	2.36e-05	0.000308	CcSEcCtD
Nelfinavir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.000306	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	2.34e-05	0.000306	CcSEcCtD
Nelfinavir—Rash—Stavudine—acquired immunodeficiency syndrome	2.34e-05	0.000305	CcSEcCtD
Nelfinavir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.34e-05	0.000305	CcSEcCtD
Nelfinavir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.34e-05	0.000305	CcSEcCtD
Nelfinavir—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.34e-05	0.000305	CcSEcCtD
Nelfinavir—Headache—Stavudine—acquired immunodeficiency syndrome	2.33e-05	0.000303	CcSEcCtD
Nelfinavir—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.33e-05	0.000303	CcSEcCtD
Nelfinavir—Pain—Delavirdine—acquired immunodeficiency syndrome	2.32e-05	0.000303	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	2.32e-05	0.000303	CcSEcCtD
Nelfinavir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.32e-05	0.000302	CcSEcCtD
Nelfinavir—Saquinavir—ALB—acquired immunodeficiency syndrome	2.31e-05	1	CrCbGaD
Nelfinavir—Rash—Abacavir—acquired immunodeficiency syndrome	2.31e-05	0.000301	CcSEcCtD
Nelfinavir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.3e-05	0.000301	CcSEcCtD
Nelfinavir—Oedema—Lamivudine—acquired immunodeficiency syndrome	2.3e-05	0.000301	CcSEcCtD
Nelfinavir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.0003	CcSEcCtD
Nelfinavir—Headache—Abacavir—acquired immunodeficiency syndrome	2.29e-05	0.000299	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	2.29e-05	0.000298	CcSEcCtD
Nelfinavir—Nausea—Nevirapine—acquired immunodeficiency syndrome	2.28e-05	0.000298	CcSEcCtD
Nelfinavir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	2.28e-05	0.000298	CcSEcCtD
Nelfinavir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.000296	CcSEcCtD
Nelfinavir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000294	CcSEcCtD
Nelfinavir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.000294	CcSEcCtD
Nelfinavir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	2.25e-05	0.000294	CcSEcCtD
Nelfinavir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000292	CcSEcCtD
Nelfinavir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000292	CcSEcCtD
Nelfinavir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000292	CcSEcCtD
Nelfinavir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	2.24e-05	0.000292	CcSEcCtD
Nelfinavir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.24e-05	0.000292	CcSEcCtD
Nelfinavir—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.23e-05	0.000291	CcSEcCtD
Nelfinavir—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	2.23e-05	0.000291	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.22e-05	0.000289	CcSEcCtD
Nelfinavir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.21e-05	0.000288	CcSEcCtD
Nelfinavir—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	2.21e-05	0.000288	CcSEcCtD
Nelfinavir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.21e-05	0.000288	CcSEcCtD
Nelfinavir—Nausea—Stavudine—acquired immunodeficiency syndrome	2.21e-05	0.000288	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000287	CcSEcCtD
Nelfinavir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000287	CcSEcCtD
Nelfinavir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	2.18e-05	0.000285	CcSEcCtD
Nelfinavir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.18e-05	0.000285	CcSEcCtD
Nelfinavir—Nausea—Abacavir—acquired immunodeficiency syndrome	2.17e-05	0.000283	CcSEcCtD
Nelfinavir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.17e-05	0.000283	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.17e-05	0.000283	CcSEcCtD
Nelfinavir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	2.16e-05	0.000281	CcSEcCtD
Nelfinavir—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.15e-05	0.000281	CcSEcCtD
Nelfinavir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	2.15e-05	0.000281	CcSEcCtD
Nelfinavir—Somnolence—Saquinavir—acquired immunodeficiency syndrome	2.15e-05	0.00028	CcSEcCtD
Nelfinavir—Pain—Ritonavir—acquired immunodeficiency syndrome	2.15e-05	0.00028	CcSEcCtD
Nelfinavir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.15e-05	0.00028	CcSEcCtD
Nelfinavir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.15e-05	0.00028	CcSEcCtD
Nelfinavir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	2.13e-05	0.000278	CcSEcCtD
Nelfinavir—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	2.13e-05	0.000277	CcSEcCtD
Nelfinavir—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.12e-05	0.000277	CcSEcCtD
Nelfinavir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.1e-05	0.000274	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000274	CcSEcCtD
Nelfinavir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.09e-05	0.000273	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.09e-05	0.000272	CcSEcCtD
Nelfinavir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.08e-05	0.000272	CcSEcCtD
Nelfinavir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.00027	CcSEcCtD
Nelfinavir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.07e-05	0.00027	CcSEcCtD
Nelfinavir—Pain—Saquinavir—acquired immunodeficiency syndrome	2.07e-05	0.000269	CcSEcCtD
Nelfinavir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.05e-05	0.000268	CcSEcCtD
Nelfinavir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.05e-05	0.000268	CcSEcCtD
Nelfinavir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.05e-05	0.000268	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.05e-05	0.000268	CcSEcCtD
Nelfinavir—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.05e-05	0.000267	CcSEcCtD
Nelfinavir—Rash—Zidovudine—acquired immunodeficiency syndrome	2.04e-05	0.000265	CcSEcCtD
Nelfinavir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.04e-05	0.000265	CcSEcCtD
Nelfinavir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.03e-05	0.000265	CcSEcCtD
Nelfinavir—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.03e-05	0.000265	CcSEcCtD
Nelfinavir—Headache—Zidovudine—acquired immunodeficiency syndrome	2.02e-05	0.000264	CcSEcCtD
Nelfinavir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.01e-05	0.000262	CcSEcCtD
Nelfinavir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2e-05	0.000261	CcSEcCtD
Nelfinavir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2e-05	0.000261	CcSEcCtD
Nelfinavir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	1.99e-05	0.00026	CcSEcCtD
Nelfinavir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	1.99e-05	0.00026	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	1.99e-05	0.000259	CcSEcCtD
Nelfinavir—Dizziness—Indinavir—acquired immunodeficiency syndrome	1.99e-05	0.000259	CcSEcCtD
Nelfinavir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000259	CcSEcCtD
Nelfinavir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000259	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	1.98e-05	0.000258	CcSEcCtD
Nelfinavir—Pain—Lamivudine—acquired immunodeficiency syndrome	1.97e-05	0.000257	CcSEcCtD
Nelfinavir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	1.95e-05	0.000254	CcSEcCtD
Nelfinavir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	1.94e-05	0.000253	CcSEcCtD
Nelfinavir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	1.92e-05	0.00025	CcSEcCtD
Nelfinavir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	1.92e-05	0.00025	CcSEcCtD
Nelfinavir—Nausea—Zidovudine—acquired immunodeficiency syndrome	1.92e-05	0.00025	CcSEcCtD
Nelfinavir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000249	CcSEcCtD
Nelfinavir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000249	CcSEcCtD
Nelfinavir—Vomiting—Indinavir—acquired immunodeficiency syndrome	1.91e-05	0.000249	CcSEcCtD
Nelfinavir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	1.9e-05	0.000248	CcSEcCtD
Nelfinavir—Rash—Indinavir—acquired immunodeficiency syndrome	1.89e-05	0.000247	CcSEcCtD
Nelfinavir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	1.89e-05	0.000247	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	1.88e-05	0.000246	CcSEcCtD
Nelfinavir—Headache—Indinavir—acquired immunodeficiency syndrome	1.88e-05	0.000245	CcSEcCtD
Nelfinavir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	1.88e-05	0.000245	CcSEcCtD
Nelfinavir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	1.86e-05	0.000242	CcSEcCtD
Nelfinavir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	1.85e-05	0.000241	CcSEcCtD
Nelfinavir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	1.83e-05	0.000239	CcSEcCtD
Nelfinavir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000238	CcSEcCtD
Nelfinavir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000238	CcSEcCtD
Nelfinavir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	1.8e-05	0.000235	CcSEcCtD
Nelfinavir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	1.8e-05	0.000235	CcSEcCtD
Nelfinavir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	1.79e-05	0.000234	CcSEcCtD
Nelfinavir—Rash—Efavirenz—acquired immunodeficiency syndrome	1.79e-05	0.000233	CcSEcCtD
Nelfinavir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	1.79e-05	0.000233	CcSEcCtD
Nelfinavir—Nausea—Indinavir—acquired immunodeficiency syndrome	1.78e-05	0.000233	CcSEcCtD
Nelfinavir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	1.78e-05	0.000232	CcSEcCtD
Nelfinavir—Headache—Efavirenz—acquired immunodeficiency syndrome	1.78e-05	0.000232	CcSEcCtD
Nelfinavir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	1.78e-05	0.000232	CcSEcCtD
Nelfinavir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	1.73e-05	0.000226	CcSEcCtD
Nelfinavir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	1.73e-05	0.000225	CcSEcCtD
Nelfinavir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	1.72e-05	0.000224	CcSEcCtD
Nelfinavir—Rash—Delavirdine—acquired immunodeficiency syndrome	1.71e-05	0.000223	CcSEcCtD
Nelfinavir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	1.71e-05	0.000223	CcSEcCtD
Nelfinavir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	1.71e-05	0.000223	CcSEcCtD
Nelfinavir—Headache—Delavirdine—acquired immunodeficiency syndrome	1.7e-05	0.000222	CcSEcCtD
Nelfinavir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	1.7e-05	0.000221	CcSEcCtD
Nelfinavir—Nausea—Efavirenz—acquired immunodeficiency syndrome	1.68e-05	0.00022	CcSEcCtD
Nelfinavir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	1.66e-05	0.000216	CcSEcCtD
Nelfinavir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	1.65e-05	0.000216	CcSEcCtD
Nelfinavir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	1.65e-05	0.000216	CcSEcCtD
Nelfinavir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	1.63e-05	0.000213	CcSEcCtD
Nelfinavir—Nausea—Delavirdine—acquired immunodeficiency syndrome	1.61e-05	0.00021	CcSEcCtD
Nelfinavir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	1.6e-05	0.000208	CcSEcCtD
Nelfinavir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	1.6e-05	0.000208	CcSEcCtD
Nelfinavir—Rash—Ritonavir—acquired immunodeficiency syndrome	1.58e-05	0.000206	CcSEcCtD
Nelfinavir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	1.58e-05	0.000206	CcSEcCtD
Nelfinavir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	1.58e-05	0.000206	CcSEcCtD
Nelfinavir—Headache—Ritonavir—acquired immunodeficiency syndrome	1.57e-05	0.000205	CcSEcCtD
Nelfinavir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.54e-05	0.0002	CcSEcCtD
Nelfinavir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.52e-05	0.000199	CcSEcCtD
Nelfinavir—Rash—Saquinavir—acquired immunodeficiency syndrome	1.52e-05	0.000199	CcSEcCtD
Nelfinavir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.52e-05	0.000198	CcSEcCtD
Nelfinavir—Headache—Saquinavir—acquired immunodeficiency syndrome	1.51e-05	0.000197	CcSEcCtD
Nelfinavir—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.49e-05	0.000194	CcSEcCtD
Nelfinavir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.47e-05	0.000191	CcSEcCtD
Nelfinavir—Rash—Lamivudine—acquired immunodeficiency syndrome	1.45e-05	0.00019	CcSEcCtD
Nelfinavir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.45e-05	0.000189	CcSEcCtD
Nelfinavir—Headache—Lamivudine—acquired immunodeficiency syndrome	1.44e-05	0.000188	CcSEcCtD
Nelfinavir—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.43e-05	0.000187	CcSEcCtD
Nelfinavir—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.37e-05	0.000179	CcSEcCtD
